Sharing Active Moiety with an Fda Approved Product Is Not Enough to Be Considered an Approved Product for the Purposes of Patent Term Extension Under 35 U S C 156
BIOGEN INTERNATIONAL GMBH v. BANNER LIFE SCIENCES LLC Before Lourie, Moore, and Chen. Appeal from the U.S. District Court for the District of Delaware Summary: If a claimed product is not the active ingredient of an FDA-approved product, or an ester or…
April 21, 2020Federal Circuit2 min read